Solara Active Pharma Reports Strong Q2 FY27 Results with PAT at Rs 28.46 Cr
Solara Active Pharma Sciences Ltd 路 Financial Result 路 16 Oct 2026, 7:08 pm
Solara Active Pharma Reports Strong Q2 FY27 Results with PAT at Rs 28.46 Cr Solara Active Pharma Sciences reported consolidated revenue from operations of Rs 417.34 Cr for the quarter ended 30th Sep'26, up 33.1% YoY from Rs 313.54 Cr and 9.4% QoQ from Rs 381.60 Cr. Profit after tax stood at Rs 28.46 Cr, swinging from a net loss of Rs 10.10 Cr in the prior-year period, despite an exceptional loss of Rs 4.50 Cr on the sale of mothballed Vizag plant CWIP. Basic EPS reached Rs 5.92. Cumulative rights issue collections stood at Rs 446.62 Cr.
Original exchange filing (PDF)
More announcements from Solara Active Pharma Sciences Ltd
- Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended September 30, 2026 路 23 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding the dispatch of Final Reminder -cum-Forfeiture Notice for the payment of outstanding call money to the holders .... 路 18 Oct 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 路 17 Oct 2026
- Audio recordings of Q2 FY27 earnings call conducted on October 16, 2026, for the quarter ended September 30, 2026 路 17 Oct 2026
- Solara Active Pharma Sciences Limited has informed the exchange about the Statement of Deviation/Variation in utilization of funds raised though Rights issue for the quarter ended September 30 2026 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding grant of 470000 options under Solara Employee Stock Option Plan 2024 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding a Press Release dated October 16, 2026, titled "Solara''s Q2 FY 27 revenue grows 33% to INR 4,178 Mn and EBITDA .... 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 8,300 Equity shares pursuant to exercise of ESOP options. 路 16 Oct 2026
